Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract

Advanced Drug Delivery Reviews

Volumn 34, Issue 2-3, 1998, Pages 191-219

  Ponchel, Gilles ^a   Irache, Juan Manuel ^b  

^a UNIV PARIS SUD   (France)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Adsorption; Bioadhesion; Conjugates; Gastrointestinal transit; Lectins; Microparticles; Nanoparticles; Oral route; Specific interactions

Indexed keywords

ADHESION; ADSORPTION; BIOCHEMISTRY; BIOPOLYMERS; DRUG INFUSION; DRUG INTERACTIONS; NANOSTRUCTURED MATERIALS; PARTICLES (PARTICULATE MATTER); PHYSICAL PROPERTIES;

BIOADHESION; GASTROINTESTINAL TRACT; LECTINS; ORAL ROUTE;

CONTROLLED DRUG DELIVERY;

NANOPARTICLE;

ADHESION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FECES LEVEL; DRUG TRANSPORT; GASTROINTESTINAL TRACT; MUCOSA; PARTICULATE MATTER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

EID: 0032403467     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00040-4     Document Type: Review

References (147)

1. Damgé C., Michel C., Aprahamian M., Couvreur P., Devissaguet J.P. Nanocapsules as carriers for oral peptide delivery. J. Control. Release. 13:1990;233-239.
2. Damgé C., Aprahamian M., Balboni G., Hoeltzel A., Andrieu V., Devissaguet J.P. Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug. Int. J. Pharm. 36:1987;121-125.
3. Damgé C., Michel C., Aprahamian M., Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 37:1988;246-251.
4. Hubert B., Atkinson J., Guerret M., Hoffman M., Devissaguet J.P., Maincent P. The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker. Pharm. Res. 8:1991;734-738.
5. Ammoury N., Fessi H., Devissaguet J.P., Dubrasquet M., Benita S. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(D,L-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Pharm. Res. 8:1991;101-105.
6. Maincent P., Le Verge R., Sado P., Couvreur P., Devissaguet J.P. Deposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles. J. Pharm. Sci. 75:1986;955-958.
7. H.O. Alpar, W.N. Field, K. Hayes, D.A. Lewis, A possible use of orally administered microspheres in the treatment of inflammation, J. Pharm. Pharmacol. 41 Suppl (1989) 50P.
8. Beck P.H., Kreuter J., Müller W.E.G., Schatton W. Improved peroral delivery of avarol with polyalkylcyanoacrylate nanoparticles. Eur. J. Pharm. Biopharm. 40:1994;134-137.
9. Damgé C., Vonderscher J., Marbach P., Pinget M. Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. J. Pharm. Pharmacol. 49:1997;949-954.
10. Bonduelle S., Carrier M., Pimienta C., Benoit J.P., Lenaerts V. Tissue concentration of nanoencapsulated radiolabelled cyclosporin following peroral delivery in mice or ophthalmic applications in rabbits. Eur. J. Pharm. Biopharm. 42:1996;313-319.
11. Ottenbrite R., Zhao R., Milstein S. A new oral microsphere drug delivery system. Macromol. Symp. 101:1996;379-387.
12. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morell C. Biologically erodible microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
13. Leroux J.-C., Cozens R., Roesel J.L., Galli B., Kubel F., Doelker E., Gurny R. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable enteric nanoparticles following intravenous and oral administration to mice. J. Pharm. Sci. 84:1996;1387-1391.
14. Volkheimer G., Schulz F.H. The phenomenon of persorption. Digestion. 1:1968;213-218.
15. Florence A.T. The oral absorption of micro and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14(3):1997;259-266.
16. Norris D.A., Sinko P.J. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J. Appl. Polym. Sci. b3(11):1997;1481-1492.
17. Ponchel G., Touchard F., Duchêne D., Peppas N.A. Bioadhesive analysis of the controlled-release systems: III. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems. J. Control. Release. 5:1987;129-141.
18. Ponchel G., Touchard F., Wouessidjewe D., Duchêne D., Peppas N.A. Bioadhesive analysis of the controlled-release systems: III. Bioadhesive and release behavior of metronidazole-containing poly(acrylic acid)-hydroxypropyl methylcellulose systems. Int. J. Pharm. 38:1987;65-70.
19. Ponchel G., Lejoyeux F., Duchêne D. Bioadhesion of polyacrylic acid containing systems. Thermodynamical and rheological aspects. Proc. Int. Symp. Control. Rel. Bioact. Mater. 18:1991;111-112.
20. C.L.C. Teng, Kinetics of adhesion of polymer-coated particles to intestinal mucous surface, Ph.D. thesis, The University of Michigan, U.M.I. Dissertation Services, Order number 8712222, Ann Arbor, 1987.
21. Teng C.L.C., Ho N.F.H. Mechanistic studies in the simultaneous flow and adsorption of polymer-coated latex particles on intestinal mucus: I. Methods and physical model development. J. Control. Release. 6:1987;133-149.
22. Durrer C., Irache J.M., Puisieux F., Duchêne D., Ponchel G. Mucoadhesion of latexes: I. Analytical methods and kinetic studies. Pharm. Res. 11:1994;674-679.
23. Durrer C., Irache J.M., Puisieux F., Duchêne D., Ponchel G. Mucoadhesion of latexes: II. Adsorption isotherms and desorption studies. Pharm. Res. 11:1994;680-683.
24. Durrer C., Irache J.M., Duchêne D., Ponchel G. Study of the interactions between nanoparticles and intestinal mucosa. Prog. Colloid Polym. Sci. 97:1994;275-280.
25. Durrer C., Irache J.M., Duchêne D., Ponchel G. Mucin interactions with functionalized poly(styrene) latexes. J. Colloid Interface Sci. 170:1995;555-561.
26. Pimienta C., Lenaerts V., Cadieux C., Raymond P., Juhasz J., Simard M.A., Jolicoeur C. Mucoadhesion of hydroxypropylmethacrylate nanoparticles to rat intestinal ileal segments in vitro. Pharm. Res. 7:1990;49-53.
27. Komiya I., Park J.Y., Kamani A., Ho N.F.H., Higuchi W.I. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 4:1980;249-262.
28. Giles C.H., Smith D., Huitson A. A general treatment and classification of the solute adsorption isotherm: I. Theoretical. J. Colloid. Interface Sci. 47:1974;755-765.
29. Elimelech M., O'Melia C.R. Effect of particle size on collision efficiency in the deposition of Brownian particles with electrostatic energy barriers. Langmuir. 6:1990;1153-1163.
30. Elaissari A., Pefferkorn E. Colloid aggregation in the presence of polymers. Effects of mobility and reactivity of clusters on the flocculation kinetics. J. Chem. Phys. 95:1991;2919-2926.
31. Peppas N.A., Hansen P.J., Buri P.A. A theory of molecular diffusion in the intestinal mucus. Int. J. Pharm. 20:1984;107-118.
32. A. Dembri, M.-J. Montisci, D. Duchêne, G. Ponchel, Degradation of poly(isobutylcyanoacrylate) nanoparticles in the presence of gastrointestinal fluids and mucus, Proc. XIème Journées Scientifiques du Groupe de Recherche Thématique sur les Vecteurs, Paris, 12-13 December, 1996, p. 68.
33. A. Dembri, M.-J. Montisci, D. Duchêne, G. Ponchel, Mucoadhesion of poly isobutylcyanoacrylate nanoparticles on the intestinal mucosa. Proc. Eur. Symp. Formulation of Poorly-available Drugs for Oral Administration, Paris, 1996, Editions de Santé, Paris, 1996, pp. 342-346.
34. Scherrer D., Mooren F.C., Kinne R.K.H., Kreuter J. In vitro permeability of PBCA nanoparticles through porcine small intestine. J. Drug Target. 1(1):1994;21-28.
35. Lenaerts V., Pimienta C., Juhasz J., Cadieux C. Bioadhesion of nanoparticles in vitro. Proc. Int. Symp. Control. Release Bioact. Mater. 16:1989;199-200.
36. Pimienta C., Chouinard F., Labib A., Lenaerts V. Effect of various poloxamer coatings on in vitro adhesion of isohexylcyanoacrylate nanospheres to rat ileal segments under liquid flow. Int. J. Pharm. 80:1992;1-8.
37. Eyles J.E., Alpar H.O., Conway B.R., Keswick M. Oral delivery and fate of poly(lactic acid) microspheres-encapsulated interferon in rats. J. Pharm. Pharmacol. 49:1997;669-674.
38. Lowe P.J., Temple C.S. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 46:1994;547-552.
39. O'Hagan D.T. Intestinal translocation of particulates - implications for drug and antigen delivery. Adv. Drug Del. Rev. 5:1990;265-285.
40. Kreuter J. Peroral administration of nanoparticles. Adv. Drug Del. Rev. 7:1991;71-86.
41. J.P. Devissaguet, H. Fessi, N. Ammoury, G. Barratt, Colloidal drug delivery systems for gastrointestinal application, in: H.E. Junginger (Ed.), Drug Targeting and Delivery - Concepts in Dosage Form Design, Ellis Horwood, New York, 1992, pp. 71-91.
42. W. Kästner, Pharmacological properties, in: C. Gloxhuber, K. Künstler (Eds.), Anionic Surfactants, Marcel Dekker, New York, 1992, pp. 419-448.
43. Pappo J., Ermak T.H. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:1989;144-148.
44. Damgé C., Defontaine L., Aprahamian M., Michel C., Humbert W., Devissaguet J.P. Preferential uptake of nanocapsules through Peyer's patches in the rat. Proc. Int. Symp. Control. Release Bioact. Mater. 18:1991;349-350.
45. Jani P., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42:1990;821-826.
46. Jani P., Halbert G.W., Langridge J., Florence A.T. Uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
47. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
48. V. Lenaerts, P. Couvreur, L. Grislain, P. Maincent, Nanoparticles as a gastrointestinal drug delivery system, in: V.M. Lenaerts, R. Gurny (Eds.), Bioadhesive Drug Delivery Systems, CRC Press, Boca Raton, 1990, pp. 94-104.
49. Kreuter J., Müller U., Munz K. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. Int. J. Pharm. 55:1989;39-45.
50. Ponchel G., Montisci M.-J., Dembri A., Durrer C., Duchêne D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharm. Biopharm. 44:1997;25-31.
51. Lehr C.M., Poelma F.G.J., Junginger H.E., Tukker J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:1991;235-240.
52. G. Ponchel, J.M. Irache, C. Durrer, D. Duchene, Products with a narrow absorption window. Rôle of bioadhesion, in: APGI and Swedish Academy of Pharmaceutical Sciences (Eds.), Minutes Collections: Formulation of Poorly Available Drugs for Oral Administration, Editions de Santé, Paris, 1996, pp. 162-173.
53. Capon C., Laboisse C.L., Wieruszeski J.-M., Maoret J.-J., Augeron C., Fournet B. Oligosaccharide structures of mucins secreted by the human colonic cancer line CL.16E. J. Biol. Chem. 267(27):1992;19248-19257.
54. G.J. Russell-Jones, Oral drug delivery via the vitamin B12 uptake system. Pharm. Manuf. Int. (1994) 81-82.
55. Mody R., Joshi S., Chaney W. Use of lectins as diagnostic and therapeutic tools for cancer. J. Pharmacol. Toxicol. Methods. 33:1995;1-10.
56. Lis H., Sharon N. Lectins as molecules and as tools. Annu. Rev. Biochem. 55:1986;35-67.
57. Naisbett B., Woodley J.F. Binding of tomato lectin to the intestinal mucosa and its potential for oral drug delivery. Biochem. Soc. Trans. 18:1990;879-880.
58. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 1. Lectin binding to rat small intestine in vitro. Int. J. Pharm. 107:1994;223-230.
59. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches. Histochem. J. 26:1994;271-280.
60. Boyd W.C., Shapleigh E. Antigenic relations of blood group antigens as suggested by tests with lectins. J. Immunol. 73:1954;226-231.
61. Goldstein I.J., Hughes R.C., Monsigny M., Osawa T., Sharon N. What should be called lectin? Nature. 285:1980;66.
62. Rini J.M. Lectin structure. Annu. Rev. Biophys. Biomol. Struct. 24:1995;551-577.
63. Kinje J.W. Functions of plant lectins. Biochem. Mol. Biol. 6:1996;180-187.
64. Peumans W.J., van Damme E.J. The role of lectins in plant defence. Histochem. J. 27:1995;253-271.
65. Drickamer K., Taylor M.E. Biology of animal lectins. Annu. Rev. Cell. Biol. 9:1993;237-264.
66. Barondes S.H., Cooper D.N.W., Gitt M.A., Leffler H. Structure and function of a large family of animal lectins. J. Biol. Chem. 269:1994;20807-20810.
67. Lasky L.A. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science. 258:1992;964-969.
68. Epstein J., Eichbaum Q., Iheriff S., Ezekowitz R.A. The collectins in innate immunity. Curr. Opin. Immunol. 8:1996;29-35.
69. Matsushita M., Endo Y., Taira S., Sato Y., Fujita T., Ichikawa N., Nakata M., Mizuochi T. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J. Biol. Chem. 271:1996;2448-2454.
70. Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins. J. Biol. Chem. 263:1988;9557-9560.
71. Bresalier R.S., Byrd J.C., Wang L., Raz A. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein gallectin-3. Cancer Res. 56:1996;4354-4357.
72. Sherblom A.P., Sathyamoorthy N., Decker J.M., Muchmore A.V. IL-2, a lectin with specificity for high mannose glycopeptides. J. Immunol. 143:1989;939-944.
73. Grillon C., Monsigny M., Kieda C. Soluble human lymphocyte sugar binding proteins with immunosuppressive activity. Immunol. Lett. 28:1991;47-55.
74. Burrows M.R., Sellwood R., Gibbons R.A. Haemagglutinating and adhesive properties associated with the K99 antigen of bovine strains of Escherichia coli. J. Gen. Microbiol. 96:1976;269-275.
75. Tewari R., MacGregor J.I., Ikeda T., Little J.R., Hultgren S.J., Abraham S.N. Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. J. Biol. Chem. 268:1993;3009-3015.
76. Karch H., Leying H., Büscher K.H., Kroll H.P., Opferkuch W. Isolation and separation of physicochemically distinct fimbrial types expressed on a single culture of Escherichia coli O7:K1:H6. Infect. Immun. 47:1985;549-554.
77. Betageri G.V., Black C.D., Szebeni J., Wahl L.M., Weinstein J.N. Fc-receptor-mediated targeting of antibody-bearing liposomes containing dideoxycytidine triphosphate to human monocyte/macrophages. J. Pharm. Pharmacol. 45:1993;48-53.
78. Irache J.M., Durrer C., Ponchel G., Duchêne D. Determination of particle concentration in latexes by turbidimetry. Int. J. Pharm. 90:1993;R9-R12.
79. Olde Damink L.H., Dijkstra P.J., van Luyn M.J., van Wachem P.B., Nieuwenhuis P., Feijen J. In vitro degradation of dermal sheep collagen cross-linked using a water-soluble carbodiimide. Biomaterials. 17:1996;679-684.
80. Irache J.M., Durrer C., Duchene D., Ponchel G. Preparation and characterization of lectin-latex conjugates for specific adhesion. Biomaterials. 15:1994;899-904.
81. I. Ezpeleta, Potentialités de protéines végétales comme materiau pour la fabrication de vecteurs particulaires, Thèse de l'Université de Rouen, 1996.
82. Ezpeleta I., Irache J.M., Stainmesse S., Chabenat C., Gueguen J., Orecchioni A.M. Preparation of lectin-vicilin nanoparticle conjugates using the carbodiimide coupling technique. Int. J. Pharm. 142:1996;227-233.
83. Ezpeleta I., Irache J.M., Stainmesse S., Gueguen J., Orecchioni A.M. Preparation of small-sized particles from vicilin (vegetal protein from Pisum sativum L.) by coacervation. Eur. J. Pharm. Biopharm. 42:1996;36-41.
84. Weissig V., Lasch J., Klibanov A.L., Torchilin V.P. A new hydrophobic anchor for the attachment of proteins to liposome membranes. FEBS Lett. 202:1986;86-90.
85. Chen H., Torchilin V., Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13:1996;1378-1383.
86. Hussain N., Jani P.H., Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14:1997;613-618.
87. C.M. Lehr, A. Puzstai, The potential of bioadhesive lectins for the delivery of peptide and protein drugs to the gastrointestinal tract, in: A. Puzstai, S. Bardocz (Eds.), Lectins. Biomedical Perspectives, Taylor and Francis, London, 1995, pp. 117-140.
88. Irache J.M., Durrer C., Duchêne D., Ponchel G. In vitro study of lectin-latex conjugates for specific bioadhesion. J. Control. Release. 31:1994;181-188.
89. de Boeck H., Lis H., van Tilbeurgh H., Sharon N., Loontiens F.G. Binding of simple carbohydrates and some of their chromophoric derivatives to soybean agglutinin as followed by titrimetric procedures and stopped flow kinetics. J. Biol. Chem. 259:1984;7067-7074.
90. Haltner E., Easson J.H., Lehr C.M. Lectins and bacterial invasion factors for controlling endo- and transcytosis of bioadhesive drug carrier systems. Eur. J. Pharm. Biopharm. 44:1997;3-13.
91. Haltner E., Easson J.H., Russel-Jones G., Lehr C.M. A rapid assay for bioadhesion of lectin-functionalized nanoparticles to Caco-2 cell monolayers. J. Control. Release. 41:1996;S3.
92. Kilpatrick D.C., Pusztai A., Grant G., Graham C., Ewen S.W.B. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett. 185:1985;299-305.
93. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 2. Mechanism of uptake in vitro. Int. J. Pharm. 110:1994;127-136.
94. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 3. Bioadhesion in vivo. Int. J. Pharm. 114:1995;227-236.
95. Lehr C.M., Bouwstra J.A., Kok W., Noach A.B.J., de Boer A.G., Junginger H.E. Bioadhesion by means of specific binding of tomato lectin. Pharm. Res. 9:1992;547-553.
96. Durrer C., Irache J.M., Puisieux F., Duchêne D., Ponchel G. Mucoadhesion of latexes: I. Analytical methods and kinetic studies. Pharm. Res. 11:1994;674-679.
97. Irache J.M., Durrer C., Duchêne D., Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13:1996;1714-1717.
98. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J. Control. Release. 36:1995;39-64.
99. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J. Drug Target. 3:1995;65-70.
100. Pusztai A., Ewen S.W.B., Grant G., Brown D.S., Stewart J.C., Peumans W.J., van Damme E.J., Bardocz S. Antinutritive effects of wheat germ agglutinin and other N-acetylglucosamine-specific lectins. Br. J. Nutr. 70:1993;313-321.
101. Noah N.D., Bender E.A., Reaidi G.B., Gilbert R.J. Food poisoning from raw red kidney beans. Br. Med. J. 281:1980;236-237.
102. Pusztai A., Ewen S.W.B., Grant G., Peumans W.J., van Damme E.J., Rubio L., Bardocz S. Relationship between survival and binding of plant lectins during small intestine passage and their effectiveness as growth factors. Digestion. 46:1990;308-316.
103. Owen R.L., Bhalla D.K. Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's patch M cells. Am. J. Anat. 168:1983;199-212.
104. Rueld C., Rieser C., Kofler N., Wick G., Wolf H. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin. Vaccine. 14:1996;792-798.
105. Uwiera R.E., Romancyia D.A., Wong J.P., Forsyth G.W. Effect of covalent modification on the binding of cholera toxin B subunit to ileal brush border surfaces. Anal. Biochem. 204:1992;244-249.
106. Uwiera R.E., Romancyia D.A., Wong J.P., Forsyth G.W. Liposomes targeted to deliver antisecretory agents to jejunal mucosa. Can. J. Vet. Res. 56:1992;249-255.
107. Caston A.J., Davis S.S., Williams P. The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems. Proc. Int. Symp. Control. Release Bioact. Mater. 17:1990;313-314.
108. Rubas W., Banerjea A.C., Gallati H., Speiser P.P., Joklik W.K. Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capacity to L929 cells in vitro. J. Microencaps. 7:1990;385-395.
109. Amerongen H.M., Wilson G.A., Fields B.N., Neutra M.R. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J. Virol. 68:1994;8428-8432.
110. Jepson M.A., Mason C.M., Clark M.A., Simmons N.L., Hirst B.H. Variations in lectin binding properties of intestinal M cells. J. Drug Target. 3:1995;75-77.
111. Giannasca P.J., Giannasca K.T., Falk P., Gordon J.I., Neutra M.R. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. (Gastrointest. Liver Physiol. 30). 267:1994;G1108-1121.
112. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:1996;316-341.
113. Isberg R.R., Falkow S. A simple genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by E. coli K-12. Nature. 317:1985;262-264.
114. Leong J.M., Fournier R.S., Isberg R.R. Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J. 9:1990;1979-1989.
115. 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 60:1990;861-871.
116. Leong J.M., Morrisey P.E., Marra A., Isberg R.R. An aspartate residue of the Yersinia pseudotuberculosis invasin protein that is critical for integrin binding. EMBO J. 14:1995;422-431.
117. 1 integrin receptor. J. Biol. Chem. 266:1991;24367-24375.
118. Hynes R.D. Integrins: a family of cell surface receptors. Cell. 50:1987;549-554.
119. Wagner N., Lohler J., Kunkel E.J., Ley K., Leung E., Krissangen G., Rajewsky K., Muller W. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature. 382:1996;366-370.
120. Menard R., Sansonetti P., Parsot C., Vasselon T. Extracellular association and cytoplasmic partitioning of the IpaB and IpaC invasins of Shigella flexneri. Cell. 79:1994;515-525.
121. Virj M., Makepeace K., Peak I.R.A., Ferguson D.P.J., Jennings M.P., Moxon E.R. Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol. Microbiol. 18:1995;741-754.
122. Young V.B., Falkow S., Schoolnik G.K. The invasin protein of Yersinia enterocolitica: internalization of invasin bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J. Cell Biol. 116:1992;197-207.
123. Hussain N., Florence A.T. Invasin-induced oral uptake of nanospheres: utilising bacterial mechanisms of epithelial cell entry. J. Control. Release. 41:1996;S3-S4.
124. Pappo J., Ermak T.H., Steger H.J. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology. 73:1991;277-280.
125. MacAdam A.B., Martin G.P., James S.L., Marriott C. Development of a novel delivery system for targeting to the gastrointestinal tract. Proc. Int. Symp. Control. Release Bioact. Mater. 19:1992;277-278.
126. MacAdam A.B., Martin G.P., James S.L., Marriott C. Preparation and characterisation of anti-porcine gastric mucus antibodies. J. Pharm. Pharmacol. 43:1991;62P.
127. Smith M.W., Thomas N.W., Jenkins P.G., Miller N.G.A., Cremaschi D., Porta C. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp. Physiol. 80:1995;735-743.
128. Zhou F., Kraehenbuhl J.P., Neutra M.R. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine. 13:1995;637-644.
129. Russell-Jones G.J., Westwood S.W., Farnworth P.G., Findlay J.K., Burger H.G. Synthesis of LHRH antagonist suitable for oral administration via the vitamin B12 uptake system. Bioconj. Chem. 4:1995;34-42.
130. Russell-Jones G.J., Westwood S.W., Habberfield A. Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin. Bioconj. Chem. 4:1995;459-465.
131. Habberfield A., Jensen-Pippo K., Ralph L., Westwood S.W., Russell-Jones G.J. Vitamin B12-mediated uptake of erythropoietin and granulocyte colony stimuling factor in vitro and in vivo. Int. J. Pharm. 145:1996;1-8.
132. Ashkenazi S. Adherence of non-fimbriated entero invasive Escherichia coli O124 to guinea pig intestinal tract in vitro and in vivo. J. Med. Microbiol. 21:1986;117-123.
133. Kopecek J., Kopecekova P., Bronsted H., Rathi R., Rihova B., Yeh P.Y., Ikesue K. Polymers for colon-specific drug delivery. J. Control. Release. 19:1992;121-130.
134. Rathi R.C., Kopecekova P., Rihova P., Kopecek J. N-(2-hydroxypropyl)-methacrylamide copolymers containing pendant saccharide moieties. Synthesis and bioadhesive properties. J. Polym. Sci., Part A. Polym. Chem. 29:1991;1895-1902.
135. Rihova B., Rathi R., Kopecekova P., Kopecek J. In vitro bioadhesion of carbohydrate containing N-(hydroxypropyl)-methacrylamide copolymers to the GI tract of guinea pigs. Int. J. Pharm. 87:1992;105-116.
136. van-Eijsdew R., Díaz C.L., de Pater B.S., Kijme J.W. Sugar-binding activity of pea (Pisum sativum) lectin is essential for heterologous infection of transgenic clover hairy roots by Rhizobium leguminosarum biovar viciae. Plant. Mol. Biol. 29:1995;431-439.
137. Smit G., Swart S., Lugtenberg B.J., Kijne J.W. Molecular mechanisms of attachment of Rhizobium bacteria to plant roots. Mol. Microbiol. 6:1992;2897-2903.
138. Goossens A., Geremia R., Bauw G., van Montagu M., Angenon G. Isolation and characterisation of arlecin-5 proteins and cDNAs. Eur. J. Biochem. 225:1994;787-795.
139. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
140. Firon N., Ofek Y., Sharon N. Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria. Infect. Immun. 43:1984;1088-1090.
141. Inohara H., Akahani S., Koths K., Raz A. Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion. Cancer Res. 56:1996;4530-4534.
142. Lasky L.A. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu. Rev. Biochem. 64:1995;113-139.
143. Avrameas A., McIlroy D., Hosmalin A., Autran B., Debre P., Monsigny M., Roche A.C., Midoux P. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur. J. Immunol. 26:1996;394-400.
144. Hostetter M.K. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev. 7:1994;29-42.
145. E.H. Beachey, Bacterial Adherence. Receptors and Recognition, ser. B, vol. 6, Chapman and Hall, London, 1980.
146. Eshdat Y., Sharon N. Recognition bacterial surface lectins which mediate its mannose-specific adherence to eukaryotic cells. Biol. Cell. 51:1984;259-266.
147. Springer W.R., Cooper D.N., Barondes S.H. Discoidin I is implicated in cell-substratum attachment and ordered cell migration of Dyctyostelium discoideum and resembles fibronectin. Cell. 39:1984;557-564.